abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
91284: Medium Chain Acyl-CoA Dehydrogenase (MCAD) Gene Sequencing Print View
MCAD Sequencing SEQUENCING     

PRIMARY
1 Whole Blood EDTA 4 (3) mL   Refrigerated - 8 Day(s)/Room Temperature - 8 Day(s)  
ALTERNATE

Based upon newborn screening results, approximately 50% of affected individuals are homozygous for the common mutation, K304E, and approximately 40% are compound heterozygous for K304E and one of the m ore than 40 other, previously described, rare alleles. Nucleotide sequences analysis can be used to detect these rare alleles and can also be used to detect novel, deleterious mutations. Therefore, nucleotide sequence analysis can be used for confirmatory diagnosis detection. In addition, it can be used for carrier testing and prenatal diagnosis.

Normal phlebotomy procedure
Setup Schedule
Wednesday

Reported (Analytical Time)
7 days

CPT Code
81479

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.






1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database